Cisplatin/Carboplatin Shortages Underscore Need for Strategies to Prevent Future Cancer Drug Disruptions

Balazs Halmos, MD, explains why a national effort is needed to mitigate current and future drug shortages in oncology and discusses strategies being used to navigate the current cisplatin and carboplatin shortages.

Related Keywords

New York ,United States ,Balazs Halmos ,Department Of Oncology ,Clinical Cancer Genomics At Montefiore Medical Center ,Albert Einstein College ,Thoracic Oncology ,Clinical Cancer Genomics ,Montefiore Medical Center ,D ,Shortage Of Cisplatin And Carboplatin ,Patients With Cancer ,Albert Einstein College Of Medicine ,